About this trial
This study is aimed at studying the efficacy and safety of treating chronic anal fissure with botulinum toxin versus lateral subcutaneous sphincterotomy.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Patients with chronic anal fissure
Disqualifiers
Inflammatory diseases of the colon
Pectenosis
Previous surgical interventions on the anal canal
IV grade internal and external hemorrhoids
Trial design
Parallel
Treatments tested in this trial
IncobotulinumtoxinA 50 U Intramuscular Powder for Solution
DrugSparing surgical removal of fissure without internal sphincter incision is held under spinal anesthesia in surgical room at lithotomy position using electrocoagulation. After that Botulinum Toxin Type A is injected into the internal anal sphincter at 1, 5, 7 and 11 o'clock (localization of injection points), 10 U at each point (40 U in total). Botulinum toxin type A (a 50 U vial) is diluted with 1.0 ml of 0.9% saline solution.
Lateral subcutaneous sphincterotomy.
Procedure/SurgeryThe patient is positioned on the table like for perineal lithotomy. After spinal anesthesia, the anal canal and then the surgical field are treated with 70% ethanol. Under the rectal speculum control, sparing surgical removal of fissure without internal sphincter incision is held using electrocoagulation.Then, in a 3 or 9 o'clock position, a narrow (eye) scalpel is inserted into the intersphincteric groove separating the external and internal sphincters, the scalpel blade is turned to the rectal lumen, and the internal sphincter is dissected up to the wall of the anal canal mucosa under the control of the finger inserted into the anal canal. After controlling hemostasis, the operation is ended with the introduction of the vent tube and hemostatic sponge.
Treatment groups
Trial outcomes
Primary outcomes
Anal sphincter insufficiency
Frequency of anal sphincter insufficiency according to the Wexner scale incontinence after the surgical intervention. Self reported daily meausure outcome, wich evaluate from 0 - to 20 points (where 0 points = full feacal continence; 20 points = full feacal incontinence).
Secondary outcomes
2-item pain intensity (P2)
Self reported pain intensity after the defecation and during the day after the surgical intervention. Each item is scored 0-10 (0 = no pain; 10 = pain as bad, as can can be).
Non-Healing Wound
Frequency of post-operative wound epithelialization
Profilometry /sphincterometry findings
Internal sphincter spasm or local internal sphincter spasm by the data of anorectal profilometry / or anorectal sphincterometry
Temporary disability
Duration of temporary disability
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
State Scientific Centre of Coloproctology, Russian Federation
Lead sponsor
St. Petersburg State Pavlov Medical University
Collaborator
Astrakhan State Medical University
Collaborator
Siberian State Medical University
Collaborator
City Clinical Hospital №24, Department of Health City of Moscow
Collaborator
GBUZ MO "Lvovskaia Raionaia Bolnica"
Collaborator
Medical Center ON-CLINIC
Collaborator